MYTHIC THERAPEUTICS
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics. The company is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Their technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets.
MYTHIC THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.mythictx.com
Total Employee:
11+
Status:
Active
Total Funding:
126.6 M USD
Technology used in webpage:
Google Apps For Business
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Morphic Therapeutic
Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series B - Mythic Therapeutics
Venrock
Venrock investment in Series B - Mythic Therapeutics
First Round Capital
First Round Capital investment in Series B - Mythic Therapeutics
Foresite Capital
Foresite Capital investment in Series B - Mythic Therapeutics
OMX Ventures
OMX Ventures investment in Series B - Mythic Therapeutics
Refactor Capital
Refactor Capital investment in Series B - Mythic Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series B - Mythic Therapeutics
Highside Capital Management
Highside Capital Management investment in Series B - Mythic Therapeutics
Viking Global Investors
Viking Global Investors investment in Series B - Mythic Therapeutics
Lifeforce Capital
Lifeforce Capital investment in Series B - Mythic Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-08-23 | Mythic Therapeutics Announces Appointment of Gilles Gallant, BPharm PhD FOPQ as Chief Development Officer |
Official Site Inspections
http://www.mythictx.com Semrush global rank: 4.56 M Semrush visits lastest month: 2.28 K
- Host name: 35.92.212.35.bc.googleusercontent.com
- IP address: 35.212.92.35
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York